Clinical Trials Directory

Trials / Completed

CompletedNCT05508711

Comparability of Transesophageal Echocardiography and FloTrac/Vigileo System Three Different Positions

Comparability of Transesophageal Echocardiography and Continuous Mini-invasive FloTrac/Vigileo System (© Edwards Lifesciences) for the Determination of Cardiac Output in Three Different Positions During General Anesthesia

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
Université Libre de Bruxelles · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The use of cardiac output monitoring to guide intraoperative fluid management and inotropic drugs as part of a hemodynamic therapy algorithm reduce the complication rate in major abdominal surgery. The FloTrac/Vigileo system (© Edwards Lifesciences) (Edwards Lifesciences, Irvine, CA) device estimate cardiac output by using arterial pulse contour analysis. The accuracy of FloTrac/Vigileo have been proven in patients with normal cardiac index. Most of studies regarding FloTrac/Vigileo were performed in patients in horizontal supine position, which is not usually the reality in the operation theater during abdominal surgery. Therefore, the investigators realized this monocentric prospective clinical trial to study the accuracy and trending ability of the fourth generation FloTrac/Vigileo system cardiac output estimation in three different positions (horizontal supine, Trendelenburg and reverse Trendelenburg positions) in anesthetized patients undergoing elective major abdominal surgery. The reference method of cardiac output measurement used was the transesophageal echocardiography.

Conditions

Interventions

TypeNameDescription
DEVICEFloTrac/Vigileo system (© Edwards Lifesciences) (Edwards Lifesciences, Irvine, CA) deviceConcomitant cardiac output measurement with transesophageal echocardiography and with the FloTrac/Vigileo system (© Edwards Lifesciences) (Edwards Lifesciences, Irvine, CA) device in 3 different positions (horizontal supine, Trendelenburg and reverse Trendelenburg position).

Timeline

Start date
2021-10-01
Primary completion
2022-01-31
Completion
2022-06-30
First posted
2022-08-19
Last updated
2022-08-19

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT05508711. Inclusion in this directory is not an endorsement.